Skip to main content
. 2014 Dec 10;3:721. doi: 10.1186/2193-1801-3-721

Figure 1.

Figure 1

SALL4-immunoreactivity in hepatocellular carcinomas. Two types of immunoreactivity are shown; diffuse intense immunoreactivity (a) and punctate immunoreactivity (b). (bar, 50 μm).